Mazy Rouhani, MD Faaem
About Mazy Rouhani, MD Faaem
Mazy Rouhani, MD FAAEM, serves as the Regional Medical Director at Envision Healthcare and holds multiple medical leadership roles, including Chief Medical Officer at Vera Health, Inc. and Medical Director at Hormone Logics and Revitalize IV Lounge, among others.
Current Roles at Vera Health, Inc
Mazy Rouhani serves as the Chief Medical Officer at Vera Health, Inc since 2022. In this role, he oversees medical operations and ensures the delivery of quality healthcare services. His leadership contributes to the strategic direction of the organization.
Medical Directorships at Hormone Logics and Revitalize IV Lounge
Since 2020, Rouhani has held the position of Medical Director at Hormone Logics in West Palm Beach, Florida. Additionally, he has been the Medical Director at Revitalize IV Lounge in Pembroke Pines, Florida since 2018. In both roles, he is responsible for clinical oversight and the implementation of medical protocols.
Educational Background in Medicine
Rouhani completed his Doctor of Medicine (M.D.) at the University of Miami Miller School of Medicine from 1997 to 1999. He also studied Emergency Medicine at Vanderbilt University and Medical Center, completing his residency from 1999 to 2002. His foundational education includes a Bachelor's degree in Microbiology and Immunology from the University of Florida, achieved from 1990 to 1993.
Experience in Medical Education
Rouhani has a significant role in medical education as an Affiliated Assistant Professor of Surgery at the University of Miami, Miller School of Medicine since 2019. He also serves as an Assistant Professor at St. George's University in Grenada since 2011 and as Clinical Faculty at Ross University School of Medicine since 2014.
Previous Leadership at Symptify
Before his current roles, Rouhani worked as Chief Operating Officer at Symptify from 2010 to 2021. His tenure there spanned 11 years, during which he contributed to operational management and strategic initiatives within the organization.